A next-generation liquid biopsy test that utilizes ultra-deep sequencing to analyze over 100 cancer-related genes, enabling highly sensitive and comprehensive genomic profiling for precision oncology.
A non-invasive blood test designed for early cancer detection, leveraging advanced molecular diagnostics to identify cancer-specific biomarkers before symptoms appear.
A screening technology that detects cancer at an early stage by analyzing circulating tumor DNA (ctDNA) and other molecular markers, providing an effective tool for proactive health monitoring.
If you would like to learn more about our products or request a quote, please feel free to reach out to us using one of the options below. We’re here to help and look forward to assisting you!
